Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

Crit Care. 2020 Jun 5;24(1):288. doi: 10.1186/s13054-020-03007-0.

Abstract

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Female
  • Humans
  • Leukocyte Count
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Neutrophils
  • Pandemics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • Predictive Value of Tests
  • Respiratory Distress Syndrome / blood*
  • Severity of Illness Index*

Substances

  • Biomarkers

Associated data

  • ChiCTR/ChiCTR2000029758